HPW Investments reveals 3.4M-share Lakewood-Amedex (LABT) position

Rhea-AI Filing Summary

Lakewood-Amedex Biotherapeutics Inc. reports a Schedule 13G filing disclosing that HPW Investments Holding Ltd. beneficially owns 3,435,501 common shares, representing 24.04% of the outstanding common stock.

The filing states the ownership percentage is calculated based on 14,290,892 ordinary shares outstanding as of March 31, 2026. HPW has sole voting and sole dispositive power over the disclosed shares. The filing is signed by Dr. Martin Kleppe on behalf of the reporting person.

Insights

Corporate Governance Analyst

Large passive stake disclosure; governance attention warranted.

The Schedule 13G shows HPW Investments Holding Ltd. holds 3,435,501 shares (24.04%) based on March 31, 2026 outstanding shares. The filing records sole voting and dispositive power, which signals the holder can influence voting outcomes.

How this affects corporate control depends on other holders and any voting agreements; subsequent filings or amendments may clarify intent or changes in ownership.

Securities Compliance Counsel

Form classification and disclosure mechanics appear standard.

The document is a Schedule 13G disclosure for common shares with CUSIP 51255A201. It includes the required beneficial ownership amount, percent calculation base, and a signature block dated 06/23/2026. The form lists citizenship and principal business address for the reporting entity.

Future material changes in holdings would trigger amendments or a different filing classification; monitor for Schedule 13D if active acquisition intent is disclosed later.

Key Figures

Beneficial ownership: 3,435,501 shares Ownership percentage: 24.04% Shares outstanding: 14,290,892 shares +1 more

4 metrics

Beneficial ownership 3,435,501 shares Amount beneficially owned by HPW Investments (Schedule 13G)

Ownership percentage 24.04% Percent of class based on shares outstanding as of March 31, 2026

Shares outstanding 14,290,892 shares Ordinary shares issued and outstanding as of March 31, 2026

CUSIP 51255A201 CUSIP for Lakewood-Amedex common shares

Key Terms

Beneficial ownership, Sole dispositive power, Schedule 13G

3 terms

Beneficial ownership regulatory

"Represents 3,435,501 shares held by HPW Investments Holding Ltd."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 3,435,501"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Schedule 13G regulatory

"Item 1. Name of issuer: LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC."

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/23/2026 - 11:10 AM Accepted by SEC EDGAR 06/23/2026 - 11:10 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.

(Name of Issuer)

COMMON SHARES, PAR VALUE $0.0001 PER SHARE

(Title of Class of Securities)

51255A201

(CUSIP Number)

04/23/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 51255A201

1

Names of Reporting Persons

HPW Investments Holding Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

JERSEY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,435,501.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,435,501.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,435,501.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

24.04 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: (1) Represents 3,435,501 shares held by HPW Investments Holding Ltd. (2) The beneficial ownership percentage is calculated based on 14,290,892 ordinary shares of the Issuer issued and outstanding as of March 31, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.
(b)	Address of issuer's principal executive offices: 8031 Cooper Creek Blvd., Unit 103, University Park, Florida 34201
Item 2.
(a)	Name of person filing: HPW Investments Holding Ltd.
(b)	Address or principal business office or, if none, residence: The Principal Business Office of the Reporting Person is: IFC 5, St. Helier, Jersey, JE1 1ST, Bailiwick of Jersey
(c)	Citizenship: Jersey, Channel Islands
(d)	Title of class of securities: COMMON SHARES, PAR VALUE $0.0001 PER SHARE
(e)	CUSIP Number(s): 51255A201
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,435,501
(b)	Percent of class: 24.04% (1) (1) The beneficial ownership percentage is calculated based on 14,290,892 shares of the Issuer issued and outstanding as of March 31, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3,435,501
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3,435,501
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

HPW Investments Holding Ltd.

Signature:	/s/ Martin Kleppe
Name/Title:	Dr. Martin Kleppe/Director
Date:	06/23/2026